Patent Assistant
MSc Biochemistry, University of Oxford
PhD Computational Developmental Biology, Heidelberg University
Thank you
June graduated from the University of Oxford in 2018 with a Master’s degree in Biochemistry. Her thesis was focused on utilising small, synthetic RNAs for gene expression in synthetic biology applications. During this time, she represented the University of Oxford in the 2015 iGEM (international Genetically Engineered Machine) competition, and engineered biofilm-degrading bacteria delivered in bead form.
She then completed a PhD in Computational Developmental Biology at Heidelberg University – EMBL (European Molecular Biology Laboratory) Barcelona. She investigated the self-organisation of periodic structures in biological development using a mouse embryo model. She also used computational models to explore to what extent these self-organising structures can be explained by mathematical concepts such as reaction-diffusion. During her PhD, she gained experience in image analysis, basic modelling, novel cell/organ culture, and mouse breeding. With her idea of applying AI-based image analysis to embryos, June won second prize in a Startup Lab pitching event organised by Heidelberg University technology transfer agency.
Originally from South Korea, June is a native speaker of Korean. In her spare time, June enjoys cooking and playing the flute.
June joined Keltie as a trainee Patent Attorney in March 2023.
06.11.2023
Sculpting proteins with code: Use of generative AI in protein designIn this article, we discuss how generative AI can provide a shortcut for developing therapeutic candidates.
02.04.2024
Patents, plausibility and data: one year on from G 2/21On 23 March 2023, the European Patent Office (EPO) Enlarged Board of Appeal (EBA) published its decision in case G 2/21, concerning plausibility in patent applications. The decision provided useful guidance on how much data needs to be disclosed in a patent application to overcome objections based on the grounds of lack of inventive step and insufficiency. One year on, we take a look at how the EPO has been applying this standard in the life sciences field.
OtherLess related knowledge
Thank you
